LB2305. Long Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection: Findings from the Extended Follow-up of the START Trial

BACKGROUND: Deferral of antiretroviral therapy (ART) initiation until CD4 count < 350 cells/μL in people with CD4 > 500 increases risk of AIDS and serious non-AIDS (SNA) conditions. Evidence from randomized trials is lacking to assess the extent to which ongoing excess risk due to having defer...

Descripción completa

Detalles Bibliográficos
Autores principales: Babiker, Abdel G, Lundgren, Jens, Sharma, Shweta, Grund, Birgit, Phillips, Andrew, Kan, Virginia L, Matthews, Gail, Klingman, Karin L, Neaton, James D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752716/
http://dx.doi.org/10.1093/ofid/ofac492.1895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752716/
http://dx.doi.org/10.1093/ofid/ofac492.1895

Ejemplares similares